InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: flipper44 post# 83832

Friday, 11/18/2016 6:14:23 AM

Friday, November 18, 2016 6:14:23 AM

Post# of 695398
Flip...very much agree with you comment as I remember a conversation with Linda and Les years ago on their European strategy with UK and Germany (multiple shots on goal) and CRC of being one indication that they would target with DCVax. Yesterday's PR is still being digested by the investment community and will be interesting to see trading volume today.

We are getting close to the finish line and possible sprint to the finish line with DCVax-L.


Congratulations to Linda Powers regarding the CRC trial.

Long time posters here know why it means a great deal to you; and fortunately, CRC's immunogenetic characteristics make it a strong target for DCVax therapy.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News